Sienna Biopharmaceuticals, Inc. Long-Term Debt
Sienna Biopharmaceuticals, Inc. had Long-Term Debt of $29.47 million as of 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2019-11-12
- 2019-06-30: Long-term Debt, Excluding Current Maturities $29.47M.
- 2019-03-31: Long-term Debt, Excluding Current Maturities $29.24M.
- 2018-12-31: Long-term Debt, Excluding Current Maturities $30.13M.
- 2018-09-30: Long-term Debt, Excluding Current Maturities $29.98M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2019-06-30 | $29.47M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $29.24M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $30.13M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $29.98M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $29.90M 10-Q · filed 2018-08-09 |